Karen Smith
2017
In 2017, Karen Smith earned a total compensation of $2.9M as Former Executive Vice President, Research and Development, CMO at Jazz Pharmaceuticals, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $287,700 |
|---|---|
| Option Awards | $915,873 |
| Salary | $516,923 |
| Stock Awards | $1,176,530 |
| Other | $10,722 |
| Total | $2,907,748 |
Smith received $1.2M in stock awards, accounting for 40% of the total pay in 2017.
Smith also received $287.7K in non-equity incentive plan, $915.9K in option awards, $516.9K in salary and $10.7K in other compensation.
Rankings
In 2017, Karen Smith's compensation ranked 3,756th out of 14,666 executives tracked by ExecPay. In other words, Smith earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,756 out of 14,666 | 74th |
Division Manufacturing | 1,307 out of 5,770 | 77th |
Major group Chemicals And Allied Products | 366 out of 2,074 | 82nd |
Industry group Drugs | 282 out of 1,730 | 84th |
Industry Pharmaceutical Preparations | 223 out of 1,329 | 83rd |
Source: SEC filing on June 15, 2018.
Smith's colleagues
We found five more compensation records of executives who worked with Karen Smith at Jazz Pharmaceuticals in 2017.
2017
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Michael Miller
Jazz Pharmaceuticals